相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism
Anu Loukola et al.
PLOS GENETICS (2015)
CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers-findings from two independent populations
Catherine A. Wassenaar et al.
CARCINOGENESIS (2015)
Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups
Sharon E. Murphy et al.
CARCINOGENESIS (2014)
Association between CYP2A6 genetic polymorphisms and lung cancer: A meta-analysis of case-control studies
Tao Liu et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2013)
Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis
Zheng-Bing Liu et al.
MOLECULAR BIOLOGY REPORTS (2013)
被撤回的出版物: Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis (Retracted article. See vol. 11, e160299, 2016)
Lishan Wang
PLOS ONE (2013)
A compensatory effect upon splicing results in normal function of the CYP2A6*14 allele
A. Joseph Bloom et al.
PHARMACOGENETICS AND GENOMICS (2013)
CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis
Yu-liang Liu et al.
TUMOR BIOLOGY (2013)
Research Opportunities Related to Establishing Standards for Tobacco Products Under the Family Smoking Prevention and Tobacco Control Act
Stephen S. Hecht
NICOTINE & TOBACCO RESEARCH (2012)
Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population
Natsuhiko Kumasaka et al.
PLOS ONE (2012)
Associations of CYP2A6 genotype with smoking behaviors in southern China
Tao Liu et al.
ADDICTION (2011)
Urinary Levels of Cigarette Smoke Constituent Metabolites Are Prospectively Associated with Lung Cancer Development in Smokers
Jian-Min Yuan et al.
CANCER RESEARCH (2011)
Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
Catherine A. Wassenaar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans
Joseph Bloom et al.
PHARMACOGENETICS AND GENOMICS (2011)
Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer Consortium
Therese Truong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior
Thorgeir E. Thorgeirsson et al.
NATURE GENETICS (2010)
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
Maria Teresa Landi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
Neal L. Benowitz
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers
Jian-Min Yuan et al.
CANCER RESEARCH (2009)
Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
M. K. Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer
Kiersten S. Derby et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeir E. Thorgeirsson et al.
NATURE (2008)
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung et al.
NATURE (2008)
Common 5p15.33 and 6p21.33 variants influence lung cancer risk
Yufei Wang et al.
NATURE GENETICS (2008)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Christopher I. Amos et al.
NATURE GENETICS (2008)
Lung cancer susceptibility locus at 5p15.33
James D. McKay et al.
NATURE GENETICS (2008)
CYP2A13: Variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
Xiuling Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
Jill C. Mwenifiumbo et al.
PHARMACOGENOMICS (2007)
Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany
Gerhard Scherer et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
Neal L. Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
V Malaiyandi et al.
MOLECULAR PSYCHIATRY (2006)
Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations
Miki Nakajima et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism
LB von Weymarn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Metabolism and disposition kinetics of nicotine
J Hukkanen et al.
PHARMACOLOGICAL REVIEWS (2005)
Cytochrome p450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen
JR Jalas et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
A meta-analytic review of the CYP2A6 genotype and smoking behavior
BL Carter et al.
NICOTINE & TOBACCO RESEARCH (2004)
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
M Fujieda et al.
CARCINOGENESIS (2004)
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
SS Hecht
NATURE REVIEWS CANCER (2003)
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population
MA Loriot et al.
PHARMACOGENETICS (2001)
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China
SJ London et al.
LANCET (2000)
分享论文
